Ignelzi Troy A. 4
4 · Rapport Therapeutics, Inc. · Filed Mar 13, 2025
Insider Transaction Report
Form 4
Ignelzi Troy A.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2025-03-13$9.98/sh+100$998→ 10,000 total - Purchase
Common Stock
2025-03-12$10.10/sh+9,900$99,990→ 9,900 total